142 related articles for article (PubMed ID: 5162299)
21. A new coronary cardio-active compound in angina pectoris.
Kundu SC; De TK; Majumdar S; Bhattacherjee TD; Mukerjee AB
J Indian Med Assoc; 1975 Sep; 65(5):136-43. PubMed ID: 765401
[No Abstract] [Full Text] [Related]
22. [Double-blind test of C.39'089-Ba in angina pectoris].
Mantykow JE; Lepera L; Slafer H; Conti L; Lo Russo J
Prensa Med Argent; 1970 Aug; 57(24):1209-12. PubMed ID: 4918476
[No Abstract] [Full Text] [Related]
23. [Influencing of hemodynamics and of serum lipids through training, oxyfedrine and lipostabil in post myocardial infarct patients].
Luther T; Liebold F; Helbig W
Z Gesamte Inn Med; 1971 Aug; 26(16):508-15. PubMed ID: 5138174
[No Abstract] [Full Text] [Related]
24. [Oxyphedrine: its positive inotropic action in normal subjects and in patients with myocardial infarct].
Jacono A; Iarussi D; Casaburi U
Minerva Cardioangiol; 1975 Sep; 23(9):571-5. PubMed ID: 1161166
[No Abstract] [Full Text] [Related]
25. Inhibition of adrenergic cardiopathies by drugs. 3. Oxyfedrin.
Eichbaum FW; Yasaka WJ; dos Campos EP; Zyngier S
Basic Res Cardiol; 1973; 68(4):335-41. PubMed ID: 4730488
[No Abstract] [Full Text] [Related]
26. Clinical experiences with oxyfedrine in patients with angina pectoris.
Raftery EB; Whittington JR
Herz; 1982 Dec; 7(6):358-65. PubMed ID: 6761258
[No Abstract] [Full Text] [Related]
27. [Clinical trial of oxyfedrine and propranolol in angina pectoris].
Chaĭtington DzhR ; Refteri EB
Ter Arkh; 1980; 52(5):59-62. PubMed ID: 6996188
[No Abstract] [Full Text] [Related]
28. [Oxyfedrine--an anti-angor drug with beta-stimulating characteristics. Bibliographic data and clinical experimentation].
Carlier J
Rev Med Liege; 1970 Dec; 25(24):797-803. PubMed ID: 5502748
[No Abstract] [Full Text] [Related]
29. [Long-term therapy of angina pectoris. Evaluation of the effectiveness and tolerance of oxyfedrine in ambulatory patients].
Schieffer H; Sternitzke N
Fortschr Med; 1984 May; 102(19):551-6. PubMed ID: 6429021
[TBL] [Abstract][Full Text] [Related]
30. [Use of a new beta-adrenergic blocking agent in angina pectoris patients (Ba 39'089)].
Ruggiero HA; Krieg R; Caprissi LF; Luzzi R
Prensa Med Argent; 1968 Jun; 55(17):805-7. PubMed ID: 5720102
[No Abstract] [Full Text] [Related]
31. Effect of oxyfedrine on exercise performance and systolic time intervals in patients of angina pectoris.
Puri VK; Agarwal SK; Mehrotra A; Hasan M
Indian Heart J; 1984; 36(4):226-30. PubMed ID: 6389320
[No Abstract] [Full Text] [Related]
32. Treatment of angina pectoris with beta-receptor blocking agents. Effects of long-term treatment and treatment with sustained release tablets.
Björntorp P
Acta Med Scand; 1971 Apr; 189(4):299-301. PubMed ID: 4398906
[No Abstract] [Full Text] [Related]
33. [Clinical experience with oxyphedrine. Action on the heart and coronary therapy (author's transl)].
Castillo Bernal A; Sáez de Santa María IE
Folia Clin Int (Barc); 1974; 24(7):573-8. PubMed ID: 4408919
[No Abstract] [Full Text] [Related]
34. [Preliminary observations on the use of oxyfedrine in the therapy of angina pectoris].
Di Lorenzo M; Puddu V
Minerva Cardioangiol; 1975 Jan; 23(1):3-6. PubMed ID: 806853
[No Abstract] [Full Text] [Related]
35. [Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
Musial W; Krzemińska-Pakula M; Tracz W
Pol Tyg Lek; 1971 Aug; 26(34):1316-8. PubMed ID: 4398697
[No Abstract] [Full Text] [Related]
36. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
Gasparotto G; Pagnan A
Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
[No Abstract] [Full Text] [Related]
37. [Treatment of coronary insufficiecy by applying retrosternal potentiated block].
Neĭmark II; Fornel' MB
Sov Med; 1966 Nov; 29(11):61-5. PubMed ID: 6015042
[No Abstract] [Full Text] [Related]
38. Left ventricular function in acute myocardial infarction before and after oxyfedrine.
Agrawal BV; Agrawal VK; Somani PN
J Indian Med Assoc; 1985 Jan; 83(1):11-4. PubMed ID: 4008944
[No Abstract] [Full Text] [Related]
39. Effect on the A-V conduction of a new antianginal drug: oxyphedryne.
Zagatti G; Benzoni A; Caturelli G
Boll Soc Ital Cardiol; 1977; 22(2):189-96. PubMed ID: 618204
[No Abstract] [Full Text] [Related]
40. [Use of heptaminol in the treatment of heart insufficiency].
Srnová V; Dolíhal J; Homola D
Vnitr Lek; 1972 Aug; 18(8):750-7. PubMed ID: 4559880
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
